SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-088661
Filing Date
2024-07-31
Accepted
2024-07-31 16:47:21
Documents
76
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20240630.htm   iXBRL 10-Q 2714883
2 EX-31.1 inva-ex31_1.htm EX-31.1 12690
3 EX-31.2 inva-ex31_2.htm EX-31.2 12691
4 EX-32 inva-ex32.htm EX-32 18351
  Complete submission text file 0000950170-24-088661.txt   12604274

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT inva-20240630.xsd EX-101.SCH 1786081
79 EXTRACTED XBRL INSTANCE DOCUMENT inva-20240630_htm.xml XML 2633231
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 241162682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)